Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...
Cancer deaths are down in the U.S., but the disease is taking hold in younger populations, likely fueled by obesity, alcohol ...
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...
Researchers investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune ...
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.
Five key safety standards are crucial for preventing occupational lung diseases. Occupational lung diseases occur when ...
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...
Republican Group Launches Taylor Swift-Themed Ad Attacking Donald Trump A woman lost 159 pounds when she quit strict diets ...
About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...